About Silexion Therapeutics Corp - Ordinary Shares (SLXN)
Silexion Therapeutics Corp is a biotechnology company focused on developing innovative therapies to address unmet medical needs in various therapeutic areas. The company specializes in the discovery and advancement of novel drug candidates utilizing its proprietary technologies. With a commitment to improving patient outcomes, Silexion aims to leverage cutting-edge research and development to create targeted treatments that enhance the quality of life for individuals suffering from complex diseases. Through collaboration with academic institutions and industry partners, Silexion strives to bring transformative healthcare solutions to market. Read More
Sept. 10, 2026 Peraso Inc. (NASDAQ: PRSO) is positioning its 60GHz millimeter-wave (mmWave) technology at the intersection of military autonomy, stealth communications, UAVs and Edge AI as the U.S. military accelerates the transition of autonomous systems from testing toward operational deployment.
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Silexion's SIL204 showed strong anti-tumor effects in preclinical tests, reaching major metastasis sites in pancreatic cancer models at human-relevant doses.
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
